How to move from a minimal to optimal pathology report?
Fredérique PENAULT LORCA
Where do we stand in developing radionuclides against molecular markers overexpressed on breast cancer (BC) cells such as EGFR-family members?
Willy Vangu
nuclear medicine, Johannesburg, South Africa
What is the importance of technical quality in breast cancer screening?
Isabelle THOMASSIN NAGGARA
radiologist, Paris, France
Comment a évoluée l’offre de soin dans le cancer du sein dans les pays émergents ces dernières années ?
Yazid BELKACEMI
Oncologue-Radiothérapeute, Créteil, France
AI-Powered Image Analysis for Breast Cancer
Gregory LENCZNER